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Background. Mycobacterium tuberculosis, the etiological agent of tuberculosis (TB), has the ability to persist in its human host
for exceptionally long periods of time. However, little is known about the location of the bacilli in latently infected individuals.
Long-term mycobacterial persistence in the lungs has been reported, but this may not sufficiently account for strictly extra-
pulmonary TB, which represents 10–15% of the reactivation cases. Methodology/Principal Findings. We applied in situ and
conventional PCR to sections of adipose tissue samples of various anatomical origins from 19 individuals from Mexico and 20
from France who had died from causes other than TB. M. tuberculosis DNA could be detected by either or both techniques in
fat tissue surrounding the kidneys, the stomach, the lymph nodes, the heart and the skin in 9/57 Mexican samples (6/19
individuals), and in 8/26 French samples (6/20 individuals). In addition, mycobacteria could be immuno-detected in perinodal
adipose tissue of 1 out of 3 biopsy samples from individuals with active TB. In vitro, using a combination of adipose cell
models, including the widely used murine adipose cell line 3T3-L1, as well as primary human adipocytes, we show that after
binding to scavenger receptors, M. tuberculosis can enter within adipocytes, where it accumulates intracytoplasmic lipid
inclusions and survives in a non-replicating state that is insensitive to the major anti-mycobacterial drug isoniazid.
Conclusions/Significance. Given the abundance and the wide distribution of the adipose tissue throughout the body, our
results suggest that this tissue, among others, might constitute a vast reservoir where the tubercle bacillus could persist for
long periods of time, and avoid both killing by antimicrobials and recognition by the host immune system. In addition, M.
tuberculosis-infected adipocytes might provide a new model to investigate dormancy and to evaluate new drugs for the
treatment of persistent infection.
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INTRODUCTION
Up to one third of the world’s population is estimated to carry
latent M. tuberculosis infections, and hundreds of millions of
tuberculosis (TB) reactivation cases are anticipated in the coming
decades if control is not strengthened [1,2]. This is particularly
true in areas of low or moderate endemicity, where most cases of
active TB result from reactivation of a latent infections [3,4].
One important and historical question regarding TB latency
deals with the location of the bacilli during that period of the
disease [5]. Numerous authors addressed this issue in the early part
of the past century using lung and lymph node necropsy samples
from individuals who had died of causes other than TB [6]. As
a proof of the high incidence of TB in Europe at the time,
tuberculous lesions were observed in most samples. Depending on
the studies, variable percentages of such lesions were found to
contain viable and infectious bacilli, as assessed by in vitro culture
or inoculation to guinea pigs [6]. Of particular interest is a study
by Opie and Aronson (1927) who reported that in addition to old
lesions, unaffected portions of the lungs may also host persistent
bacilli [7]. These results have been recently confirmed and
expanded by Herna ´ndez-Pando et al. (2000), who reported in situ
PCR-detection of M. tuberculosis DNA in normal-appearing lung
tissues from about 35% of the necropsy specimen included in the
study [8].
Apart from the lungs and the lymph nodes, other organs and
tissues are likely to host persistent bacilli during TB latency.
Indeed, a striking feature of reactivating TB is that nearly 15% of
the cases occur at extra-pulmonary sites, including the brain, the
meninges and the spinal cord, the skin, the internal organs, and
the genitourinary tract, without apparent pathology in the lungs
[9,10]. In those cases, it is most likely that growth of the bacilli
resumes directly from the reactivation foci rather than from
pulmonary sites and subsequent migration of the bacteria to other
body sites.
The adipose tissue constitutes 15–25% of the total body mass
and is broadly distributed throughout the body. Possible interac-
tions between this tissue and mycobacteria have not been
rigorously investigated. Here, we have investigated these interac-
tions by using a combination of adipose tissue models, including
the widely used 3T3-L1 murine adipose cell line as well as human
primary adipocytes and adipose tissues from patients with active
pulmonary TB or from individuals who died of causes other than
TB. Altogether, our results suggest that the adipose tissue might
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tubercle bacillus could persist in a dormancy-like state and avoid
both anti-mycobacterial drugs and host defence mechanisms.
METHODS
Bacteria and cells
M. tuberculosis strains were propagated at 37uC in complete
Middlebrook 7H9 medium. 3T3-L1 fibroblasts were cultured in
DMEM (Invitrogen) containing 10% heat-inactivated foetal calf
serum (FCS; Dutscher), at 37uC under 5% CO2. At confluency,
pre-adipocytes stop dividing. Adipocyte differentiation was
initiated at confluency (day 0) by adding 100 mM 3-isobutyl-1-
methylxanthine (IBMX), 250 nM dexamethasone (DM), and
1 mg/ml bovine insulin (all from Sigma) into the culture medium.
At day 2, medium was replaced by DMEM-10% FCS containing
1 mg/ml insulin only. Full differentiation was reached at day 8–10,
as assessed by red oil staining of lipid droplets. Human adipose
cells obtained from plastic surgery wastes were differentiated in
vitro using appropriate differentiation and nutrition media
(PromoCell).
Mycobacterial intracellular survival and binding
experiments
Cells were infected at a multiplicity of infection (MOI) of 1
bacterium per cell for 4 h at 37uC, washed with serum-free
DMEM, and further incubated with fresh complete medium.
Mature adipocytes were infected at day 10 after differentiation. At
various time-points, cells were washed with serum-free DMEM,
lysed in distilled water containing 0.01% Triton X-100 (Sigma),
and the lysates were plated at various dilutions onto 7H11 agar. In
some instances, cells were incubated with 200 mg/ml amikacin 2 h
prior lysis in order to kill extra-cellular bacteria. Plates were
incubated at 37uC for 18–20 days after which colony-forming
units (CFUs) were scored. For binding experiments, cells that had
been pre-incubated with various inhibitors for 30 min at 4uC,
were infected with bacteria at a MOI of 1 for 4 h at 4uC in the
presence of the inhibitors, washed in serum-free DMEM, and
treated as described above for CFUs scoring. Fucoidan, poly-
adenosinic acid, and polyinosinic acid (all from Sigma) were used
at 0.1 mg/ml. PAz-PC (Cayman), a major component of oxidized
low-density lipoprotein was from used at 0.01 mg/ml. All
antibiotics used in the study were from Sigma. For quantification
of mycobacterial chromosome equivalents (CEQs) in infected cells,
we followed a previously described procedure for quantitative real-
time PCR amplification of the sigF gene [11].
Electron microscopy
Cells were fixed in 2.5% glutaraldehyde in 0.1 M cacodylate
buffer, pH 7.4, for one hour at room temperature. After 3 washes
in the same buffer, cells were postfixed in 1% osmium tetroxide in
0.1 M cacodylate buffer, pH 7.2, for 1 hour at room temperature.
The cells were then washed three times in cacodylate buffer, rinsed
in 30% methanol, and stained for 1 hour in uranyl acetate. The
cells were then dehydrated in a graded series of ethanol solutions
(from 25 to 100%) before being embedded in Spurr resin at 60uC.
Ultrathin sections were cut on an Ultracut UCT microtome
(Leica) and then examined under a JEM1010 microscope (Jeol) at
80 Kv accelarating voltage. For immuno-staining for perilipin A/
B, the cells were fixed in 3% paraformaldehyde and 0.2%
glutaraldehyde in 0.1 M phosphate-buffered saline (PBS), pH 7.4,
for 1 hour at room temperature. The cells were washed three
times in the same buffer before embedded in 10% gelatine and
then infused in 1.7 M sucrose +15% polyvinyl pyrolidone for
4 hours at 4uC. Cells were then cryosectionned in Ultracut FCS
microtome (Leica) at 2130uC, and then immunolabelled, after
quenching of free aldehyde groups and blocking in 0.1% BSA in
PBS. Cryosections were incubated in anti-perilipinA/B rabbit
IgGs (Affinity BioReagents) used at 1/100 dilution in 0.1% BSA in
PBS containing 0.1% fish gelatin (PBG), for 1 hour at room
temperature. After six washes in PBS containing acetylated BSA
(Aurion), cells were incubated with a goat-anti-rabbit F(ab9)2
fragments conjugated to 10 nm gold particles (BBinternational)
used at 1/25 dilution in PBG. The preparations were negatively
stained with uranyl acetate, embedded in methyl cellulose
following the Tokuyasu method, and observed under the
microscope.
Human samples
Individuals who had died from causes other than tuberculosis were
autopsied in the Department of Pathology at the General Hospital
of Mexico, or in the Department of Anatomo-Pathology at the
Georges Pompidou European Hospital of Paris. As soon as
possible after death, blocks of various tissues from 3 to 5 cm were
sectioned and fixed in 10% formaldehyde dissolved in PBS. After
fixation, the tissues were dehydrated in graded ethyl alcohol
concentrations and embedded in paraffin. For histological
examination, 5 mm sections stained with hematoxylin and eosin
were obtained. The same paraffin blocks were used for
mycobacterial DNA localization by in situ-PCR. Tissues were
obtained for the exclusive purpose of the legally authorized
autopsy and no additional samples were taken for the purpose of
the present study. Lymph nodes from three patients with active TB
were referred to the Laboratory of Pathology at the Saint-Louis
Hospital (Paris, France) for the purpose of TB diagnosis with the
patient’s consent and used according to institutional guidelines.
Treatment of the biopsy and immunodetection of M. tuberculosis
antigens were achieved as previously published [12].
In situ and conventional PCR
Five microns width sections from the paraffin blocks were
mounted on silane coated slides, deparaffinized for 18 h at 60uC
and sequentially immersed in xylene (30 min at 37uC), absolute
ethanol, 75%, 50%, 25% ethanol and water. Cells were rendered
permeable by incubation for 10 min at room temperature in
0.02 M HCl. Then proteins were depleted by incubation with
proteinase K 1 mg/ml (Gibco) for 30 min at 37uC. The proteinase
was then inactivated by boiling in a microwave for 15 sec and the
section plunged immediately into 20% acetic acid for 15 sec to
inactivate endogenous alkaline phosphatase. The polymerase
chain reaction was carried out by incubating the sections with
50 mlo f1 6reaction buffer (Gibco, BRL), 1.5 U Taq polymerase,
2 mM MgCl2,4 0mM dNTP, and 0.2 mM dUTP labeled with
digoxigenin (Boehringer Manheim), and 60 pg each of IS6110 M.
tuberculosis insertion sequence primers. The sequence of the primers
was: 59-CCCTGCGAGCGTAGGCGTCGG-39sense and 59-
CTCGTCCAGCGCCGCTTCGG-39antisense. The slides were
sealed using the Assembly tool (Perkin Elmer) and placed in the
thermocycler (Touch Down, Hybaid). The M. tuberculosis DNA
amplification started with denaturation at 94uC for 1 min,
annealing at 70uC for 1 min, and extension at 72uC for 1 min,
for 35 cycles. PCR products were detected with sheep anti-
digoxigenin antibodies coupled to alkaline phosphatase (Boehrin-
ger Manheim) diluted 1/500. The chromogen was 5 bromo-4-
chloro-3-3 indolyl phosphate toluidine salt (BCIP) and tetrazolium
nitroblue (Boehringer Manheim) diluted 1/50. Sections were
Adipose Tissue in Tuberculosis
PLoS ONE | www.plosone.org 2 December 2006 | Issue 1 | e43Figure 1. M. tuberculosis persists in a non-replicating state inside adipocytes. A. 3T3-L1 mouse (grey bars) and primary human (black bars)
adipocytes were infected with M. tuberculosis, clinical isolate MT103, at a MOI of 1. Mycobacterial binding to the cells was measured after 4 h at 4uCi n
the presence of various inhibitors. Man, yeast mannan; LAM, lipoarabinomannan; pA, polyadenosinic acid; pI, polyinosinic acid; Fuc, fucoidan; PC, PAz-
PC, a predominant form of oxidized low-density lipoprotein. Results are expressed as % of the binding without inhibitor (Ø). B. 3T3-L1 adipocytes
(grey bars) and pre-adipocytes (black bars) were infected as described in A. in the presence of Fuc or PAz-PC. Mycobacterial binding was assessed and
analysed as in A. C. 3T3-L1 pre-adipocytes (black squares) and adipocytes (open squares) were pulsed with M. tuberculosis MT103 at a MOI of 1 for 4 h
at 37uC, then chased with fresh medium. Mycobacterial survival, expressed as % of the bacterial load at day 0, was monitored on a 10-day period. The
results are standardized as % of the bacterial load at day 0 because of the differential M. tuberculosis binding to adipocytes and pre-adipocytes. D.
3T3-L1 adipocytes were infected as described in C. Viable counts (CFU) were quantified by plating serial dilutions of cell lysates (open bars), and total
counts (CEQ) were quantified by qPCR (grey bars). E. 3T3-L1 adipocytes were infected as described in C. In order to kill extra-cellular bacteria cells
were pre-incubated with 200 mg/ml amikacin 2 h prior lysis and plating. Results are expressed as % of bacterial load at day 0. F. 3T3-L1 adipocytes
and pre-adipocytes were infected as described in C. Cells were treated with 1 mg/ml rifampicin (Rif), 0.1 mg/ml isoniazid (Inh), 25 mg/ml pyrazinamide
(Pza) or 5 mg/ml ethambutol (Emb) at day 3, and bacterial loads were quantified at day 5. Results are expressed as % of bacterial load at day 5 in the
absence of antibiotics (Ø). In all panels, results are the mean of three independent experiments and bars indicate 6 sd. NT, not tested; NS, not
significant, and *, p,0.05, as assessed by Mann-Whitney test of median comparison.
doi:10.1371/journal.pone.0000043.g001
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the blue signal generated by mycobacterial DNA in the in situ
PCR. Lung sections from 6 tuberculous autopsies were used as
positive controls. The negative control consisted of performing the
whole procedure with non-infected mouse lung. A further control
was the use, on the same slide as the test section, of a duplicate
section to which PCR mix was added without Taq and another
section added without primers. Conventional PCR to amplify
IS6110 in tissue extracts was performed as previously described
[8].
RESULTS
M. tuberculosis binds to adipocytes through
scavenger receptors
The ability of adipocytes to act as macrophage (Mw)-like and to
phagocytose particles, including live microorganisms, has been
demonstrated recently using the 3T3-L1 murine cell line as
a model [13,14]. Under appropriate stimulation, 3T3-L1 cells can
differentiate into adipose cells similar to those of the white adipose
tissue [15]. In order to determine whether mycobacteria could
bind to adipocytes and, if so, which cellular receptor(s) might be
involved in this process, we carried out cold binding assays by
incubating live M. tuberculosis (clinical strain MT103) with 3T3-L1
adipocytes in the presence or absence of various inhibitors. Cells
were infected at a multiplicity of infection (MOI) of 1 bacterium
per cell. After 4 h at 4uC, nearly 10% of the initial inoculum
(9,600 6 500 colony-forming units, CFUs, per 100,000 cells, noted
as 100% on Figure 1A) were found attached to the cells in the
absence of inhibitor. As mycobacteria are exceptionally rich in
glyco-conjugates, especially in mannosylated compounds that can
interact with a variety of host cell surface lectins [16], we
considered yeast mannan and M. tuberculosis lipoarabinomannan
(LAM), a major mannose-rich lipoglycan of the mycobacterial
envelope, as possible inhibitors in the assay. None of these
compounds could inhibit mycobacterial binding to the cells
(Figure 1A), suggesting that mannose residues of the bacterial cell
envelope are not involved in the binding process. Adipocytes
express numerous scavenger receptors (SRs), and mycobacterial
binding to SRs on monocyte-derived Mws has been reported [17].
We thus next considered SRs as candidate M. tuberculosis receptors
on adipocytes, and we included SR ligands as possible inhibitors in
the assay. Interestingly, the polyanionic SR ligands polyinosinic
acid (polyI) and fucoidan, as well as 1-palmitoyl-2-azelaoyl
phosphocholine (PAz-PC), one of the predominant oxidized low
density lipoprotein (OxLDL) species [18], could inhibit mycobac-
terial binding to the cells of 25%, 60%, and 90%, respectively
(Figure 1A). As a control, polycationic ligands, such as
Figure 2. M. tuberculosis accumulates lipid droplets inside adipocytes. 3T3-L1 mouse adipocytes (A–C&E) and pre-adipocytes (D) were pulsed with
M. tuberculosis MT103 at a MOI of 1 for 4 h, then chased with fresh medium for 24 h and observed by electron microscopy. In A., the arrow indicates
a mycobacterial vacuole shown at higher magnification in the inset; LD, lipid droplet; bar=2 mm. In B., perilipinA/B was immuno-stained with gold-
conjugated antibodies. Mtb, M. tuberculosis; bar=200 nm. In C, bar=500 nm. In D&E, bar=200 nm. F. Electron micrographs of 2 independent
experiments were used to quantified lipid droplet accumulation inside mycobacteria when within adipocytes and pre-adipocytes. An average of 50
mycobacteria were observed in different fields in each sample.
doi:10.1371/journal.pone.0000043.g002
Adipose Tissue in Tuberculosis
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(Figure 1A). Similar results were obtained in human primary
adipose cells extracted from plastic surgery wastes and infected as
described above. Again, SR ligands, such as polyI, fucoidan and
PAz-PC could inhibit mycobacterial attachment to adipocytes of
up to 80%, while polyA had no effect on the binding process
(Figure 1A). These results demonstrate that M. tuberculosis can bind
to adipocytes of murine or human origin through SRs. In-
terestingly, the most potent binding inhibitors in adipocytes,
namely fucoidan and PAz-PC, had no effect on mycobacterial
attachment to 3T3-L1 pre-adipocytes (Figure 1B).
M. tuberculosis persists in a non-replicating state
within adipocytes
We next evaluated the ability of adipose cells to phagocytose
mycobacteria by pulsing infected 3T3-L1 cells at 37uC. After 24 h
infection, observation of the cells under the electron microscope
clearly showed intracellular bacilli within membrane-bound
vacuoles (Figure 2A–E). In some cases, mycobacterial vacuoles
were found to fuse with lipid droplets (Figure 2B), as revealed by
immuno-detection of perilipins, that are specific to the surface of
lipid droplets in adipocytes [19]. A few bacilli were observed inside
vacuoles whose amorphous lumen resembled lipid droplet content,
and that most likely resulted from the fusion between the
mycobacterial vacuoles and pre-existing lipid droplets
(Figure 2C); in these cases, mycobacteria were heavily loaded in
small electron-dense vesicles resembling lipid inclusions. Whereas
mycobacteria barely carried lipid inclusions in pre-adipocytes
(Figure 2D&F), they were commonly loaded in such inclusions in
mature adipocytes (Figure 2E&F).
Pathogenic mycobacteria are known for their ability to
parasitize Mws, which are the first M. tuberculosis host cells in the
lungs, and to multiply within these cells with a replication time of
about 20 h [20]. Apart from Mws, other cell types, including
fibroblasts and epithelial cells, have been shown to be permissive to
mycobacterial replication [21,22,23]. In order to evaluate whether
mycobacteria could also replicate in adipocytes, 3T3-L1 adipo-
cytes were pulsed with live mycobacteria for 4 h at 37uC at a MOI
of 1, and chased with culture medium. At various time-points after
infection, cells were lysed and their bacterial content was measured
by plating lysates onto agar and scoring CFUs. Surprisingly,
mature adipocytes were not permissive to mycobacterial growth
over a 10-day period (Figure 1C). Interestingly, the mycobacterial
stasis observed in adipocytes correlated with cell differentiation
and accumulation of lipid droplets, as fibroblast-like pre-
adipocytes allowed mycobacterial replication with a doubling time
of about 40 h (Fig. 1C), which is less than the commonly observed
values in macrophages. No obvious cytotoxicity was noticed in
pre-adipocytes along infection. In order to investigate whether
mycobacteriostasis corresponded to genuine persistence of the
bacillus in a non-dividing state, or to a mix of killing and
replication, we quantified the number of chromosome equivalents
(CEQs) in infected 3T3-L1 adipocytes following a recently
described procedure [11]. Our results thus suggest that M.
tuberculosis persists in a non-replicating state in adipocytes
(Figure 1D). Treatment of the infected cells for 2 h with
a mycobactericidal dose of the membrane-impermeant antibiotics
amikacin prior to cell lysis and bacteria plating indicated that
persisting bacilli were mostly intracellular (Figure 1E). We next
reasoned that anti-mycobacterial drugs, such as isoniazid (INH),
known to act exclusively on non-dormant actively dividing bacilli
[24] should have only moderate effects, if any, on intra-adipose
cell mycobacteria. On the other hand, drugs such as pyrazinamide
(PZA), known to affect cell viability in dormant bacilli [25], should
prove efficacious at killing M. tuberculosis when inside adipocytes.
We infected adipocytes with M. tuberculosis as described above, and
treated the cells with INH at day 3 after infection, and evaluated
the bacterial load of the cells at day 5. INH had no significant
effect on M. tuberculosis in adipocytes (Figure 1F). By contrast, the
bacterial load was reduced by 5–10 fold in 3T3-L1 pre-adipocytes
infected and treated in the same manner (Figure 1F). An opposite
pattern was observed for PZA, that showed no significant effect on
mycobacterial viability in pre-adipocytes, but reduced, significant-
ly although less than rifampicin and ethambutol, the bacterial load
in mature adipocytes of 30–50% (Figure 1F). We also assessed the
ability of two other major anti-mycobacterial drugs commonly
used to treat TB, namely rifampicin (RIF) and ethambutol (EMB),
to inhibit mycobacterial persistence in adipocytes. Both EMB and
RFP could reduce bacterial load of 80–90% in both adipocytes
and pre-adipocytes (Figure 1F).
Figure 3. Detection of M. tuberculosis in adipose tissue from
individuals with latent or active TB. A. Perinodal adipose tissue was
taken from biopsy of the mediastinal lymph node from a patient with
active TB. Bacilli were immuno-detected using an anti-BCG rabbit
hyperimmune serum (right panel). As a control, a serial section was
stained with serum from a naı ¨ve animal (left panel). B. Perinodal
adipose tissue was taken at autopsy from two individuals (upper and
lower panels) with no clinical sign of pulmonary TB. In situ PCR was used
to detect IS6110. In A&B, arrows indicate positive signals.
doi:10.1371/journal.pone.0000043.g003
Adipose Tissue in Tuberculosis
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individuals with latent or active TB
Finally we wished to evaluate whether adipose tissue could be
targeted by M. tuberculosis during natural infection in humans. To
accomplish this we obtained peri-nodal adipose tissue biopsy
samples from 3 patients with active TB. Immuno-detection of M.
tuberculosis using an anti-BCG hyperimmune serum revealed the
presence of the bacillus in samples from one individual (Figure 3A).
Although this result, due to the limited number of samples
available, does not allow us to make a general statement about
infection of adipose tissue during active TB, it does indicate that
the bacillus can access this tissue, at least around the mediastinal
lymph node during active disease.
In order to evaluate whether M. tuberculosis might persist in
adipose tissue in individuals with latent TB, we obtained 57 peri-
renal, abdominal and peri-nodal adipose tissue samples from 19
autopsy cases of Mexican individuals who died from causes other
than TB, and we proceeded to detect mycobacterial DNA
(IS6110)b yin situ as well as conventional PCR. Nine samples
(representing 6 individuals) showed positivity for mycobacterial
DNA by either or both techniques (illustrated in Figure 3,
recorded in Table 1). Since these individuals had no sign of TB at
autopsy, it is likely that they carried latent infections. However, TB
is highly endemic in Mexico and we cannot exclude that those
individuals with PCR positivity had not been infected recently
before they died. We thus made similar investigations using 26
autopsy samples from 20 French individuals who died in Paris
where TB is not endemic. As illustrated in Table 2, we could show,
by both in situ and conventional PCR, the presence of M.
tuberculosis DNA in 4 samples (representing 4 individuals) taken
from heart, kidney, skin and lymph node adipose tissue. A total of
8 samples (representing 6 individuals) were found positive by either
or both technique. Some discrepancy between the two techniques
have already been reported [8], and are likely due to the different
autopsy sample slices used to realize the assays. Although DNA
detection does not formally prove the presence of the bacillus in
a viable form, as compared to culture or inoculation to guinea
pigs, it suggests past exposure.
DISCUSSION
In summary, this study reveals that M. tuberculosis can persist
without replication inside adipocytes in vitro and likely in adipose
tissue in vivo in naturally infected humans with either active or
latent TB. Our in vitro results are reminiscent of those of two
previous studies reporting that neither the vaccine strain
Mycobacterium bovis bacille Calmette-Gue ´rin (BCG) nor Mycobacte-
rium leprae, the etiological agent of Hansen’s disease or leprosy,
could multiply when cultivated onto adipose tissue, whereas the
bacteria replicated well in a variety of other tissues [26,27]. Here,
we have shown that M. tuberculosis enters into adipocytes after
binding to SRs. The finding that PAz-PC, one of the major species
of OxLDL inhibits M. tuberculosis binding to adipose cells may
suggest participation of CD36 in the binding process, as this
particular SR has been reported to mediate internalization of
OxLDL by adipocytes [28,29]. After entry, we have shown that
mycobacteria can persist within adipocytes without apparent
replication. This was not the case in pre-adipocytes in which
mycobacteria could multiply, which might rely on the different
receptors used by the bacillus to enter the two cell types.
This phenomenon could also depend on the host cell lipid
metabolism as only mature adipocytes, but not fibroblastic pre-
Table 1. Detection of M. tuberculosis DNA in adipose tissue from Mexican autopsy samples
a
..................................................................................................................................................
Patients’ characteristics Presence of mycobacterial DNA (PRAT/PAT/PNAT)
b
Patient # Sex Age at death (Years) Cause of death In situ PCR Conventional PCR
1 F 69 Sepsis 2/2/22 /2/2
2 F 18 Sepsis 2/2/22 /2/2
3 M 35 Hypovolemic shock +/2/++ /2/2
4 M 64 Lung cancer 2/+/22 /+/2
5 M 42 Malignant glioma 2/2/22 /2/2
6 F 57 Sepsis 2/2/22 /2/2
7 M 89 Pneumonia +/+/22 /2/2
8 M 29 Myeloblastic leukemia 2/2/22 /2/2
9 F 29 Kidney cancer 2/2/+ 2/2/2
10 M 80 Emphysema 2/2/+ 2/2/+
11 F 29 Hypovolemic shock 2/2/22 /2/2
12 F 83 Stroke +/2/+ 2/2/2
13 F 22 Diabetes 2/2/22 /2/2
14 M 36 Stroke 2/2/22 /2/2
15 F 70 Breast cancer 2/2/22 /2/2
16 F 50 Heart failure 2/2/22 /2/2
17 M 76 Heart failure 2/2/22 /2/2
18 F 59 Chronic kidney failure 2/2/22 /2/2
19 F 14 Sepsis 2/2/22 /2/2
aNine samples were positive for mycobacterial DNA by in-situ PCR, and three by conventional PCR. Three of these nine were positive by both methods. Six samples were
positive only by in-situ PCR, and no sample was positive only by conventional PCR. Thus 51 of 57 samples were concordant by the two methods
bPRAT, peri-renal adipose tissue; PAT, peritoneal adipose tissue; PNAT, peri-nodal adipose tissue
doi:10.1371/journal.pone.0000043.t001
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PLoS ONE | www.plosone.org 6 December 2006 | Issue 1 | e43adipocytes, could restrict mycobacterial growth. Inside adipocytes,
mycobacteria were found to accumulate electron-dense lipid
droplets. Recently, it has been suggested that sequestration of
host fatty acids in cytoplasmic lipid droplets by mycobacteria may
allow the bacilli to survive in a non-replicating state [30]. More
generally, accumulation of triacylglycerols inside the cytoplasm of
various actinomycetes is thought to be associated with bacterial
survival under conditions of stress, such as limited aeration [31].
Our results are also reminiscent of a previous study in which the
ability of two calixarenes, namely HOC-12.5 (macrocyclon) and
HOC-60, to respectively inhibit and enhance M. tuberculosis growth
in Mws was correlated to the ability of these drugs to respectively
induce and prevent accumulation of lipid droplets within the cells
[32]. Altogether, the previous studies and our results stress the
importance of the host cell lipid metabolism in mycobacterial
infections. In adipose cells, it is likely that mycobacteria use
lipolytic enzymes to degrade host cell triglycerides and import fatty
acids in their cytoplasm. Analysis of the M. tuberculosis complete
genome has revealed that the bacillus possesses nearly 20 putative
lipases [33]. The use of M. tuberculosis lipase-deficient mutants will
be useful to delineate the metabolic interactions between the
bacillus and adipose cells.
Mycobacterial behaviour within adipocytes may be interesting
to further investigate as a model of persistence, as compared to
other currently used in vitro models of mycobacterial dormancy.
Adipocyte differentiation is associated with high O2 consumption
and hypoxia is known to prevent triglyceride accumulation in
differentiating adipose cells and adipogenesis [34]. An attractive
hypothesis is that access of mycobacteria to O2 may be limited
within adipocytes, which may induce mycobacterial dormancy. In
this view, it will be interesting to compare M. tuberculosis
metabolism in adipose cells to that of dormant bacilli in the O2
deprivation-induced Wayne’s dormancy model [24].
The adipose tissue is distributed throughout the body and
represents 15–25% of the total body mass. This tissue may thus
constitute, among others, a vast mycobacterial reservoir, allowing
the bacilli to persist virtually anywhere in the body. In this aspect,
it is interesting that we could show the presence of M. tuberculosis
DNA in adipose tissue samples of various anatomical origins taken
at autopsy in a public hospital in Paris. Since TB is not endemic in
Paris, it is unlikely that those individuals with PCR positivity had
been infected recently before they died. In particular, they showed
no sign of pulmonary TB at autopsy. Although DNA detection
does not formally prove the presence of the bacillus as compared
Table 2. Detection of M. tuberculosis DNA in adipose tissue from French autopsy samples
a
..................................................................................................................................................
Patients’ characteristics Presence of mycobacterial DNA
Patient # (Sample #) Sex Age at death (Years) Cause of death Sample origin In situ PCR Conventional PCR
1 (1) M 68 Aortic disruption Mediastinum 2 +
1 (2) M 68 Aortic disruption Mediastinum 2 +
1 (3) M 68 Aortic disruption Mediastinum + 2
2 F 45 Pulmonary embolism Diaphragm 22
3 M 58 Respiratory failure Heart 22
4 F 83 Pulmonary embolism Abdominal muscle 22
5 F 76 Peritonitis Heart ++
6 M 74 Heart failure Kidney ++
7 F 90 Pneumonia Peritoneum 22
8 F 45 Pulmonary carcinoma Diaphragm 22
9 F 73 Stroke Heart 22
10 (1) F 69 Peritonitis Skin ++
10 (2) F 69 Peritonitis Intestine 22
11 (1) F 80 Peritonitis Intestine 2 +
11 (2) F 80 Peritonitis Intestine 22
12 M 89 Heart failure Kidney 22
13 (1) M 91 Heart failure Kidney 22
13 (2) M 91 Heart failure Coronary artery 22
14 F 40 Acute pancreatitis Heart 22
15 M 72 Pulmonary embolism Intestine 22
16 M 59 Myocardial infarction Kidney 22
17 M 40 Myocardial infarction Pancreas 22
18 F 58 Heart Failure Breast 22
19 (1) M 33 Pneumonia Mediastinal lymph node 22
19 (2) M 33 Pneumonia Mediastinal lymph node ++
20 M 80 Coronary heart disease Heart 22
aFive samples were positive for mycobacterial DNA by in-situ PCR, and seven by conventional PCR. Four of these five were positive by both methods. One sample was
positive only by in-situ PCR, and three others were positive only by conventional PCR. Thus 22 of 26 samples were concordant by the two methods
doi:10.1371/journal.pone.0000043.t002
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In an attempt to detect intact bacilli in these PCR-positive
samples, we performed Ziehl-Nielsen staining. Unfortunately no
sample could be stained using this technique (data not shown).
This is likely due to the low bacterial load within the samples, and/
or to modification of the cell wall of dormant bacilli [35,36,37].
Reactivation of persistent M. tuberculosis infection in the adipose
tissue might account, at least in part, for extra-pulmonary TB,
which represent about 15% of the total reactivation cases [9,10].
How, following entry by the respiratory route, the bacilli
subsequently reach extra-pulmonary adipose tissue remains to be
determined. However, we can anticipate that both hematogenous
and cell-mediated (eg by migrating dendritic cells) routes contribute
to this process. Once inside adipocytes, we have shown that the
tubercle bacillus exhibit increased and diminished resistance to
INH and PZA, respectively, which might consistent with
a dormancy-like state of the bacilli inside the cells. However,
another possible explanation might rely on the differential
hydrophilicity of these antibiotics. RFP and EMB are lipophilic,
while INH is hydrophilic. This will have to be further explored, for
instance by examining the levels of antibiotics inside the cells. It is
also known that PZA has a better antimicrobial activity at acidic
pH. Whether M. tuberculosis resides in an acidified intracellular
compartment inside mature adipocytes remains to be studied. If
genuine, these findings might have to be taken into account for the
future design of antibiotics-based therapeutic strategies. For
instance, the use of INH only in preventive therapy, especially
in HIV-infected individuals, might not be sufficient to prevent
reactivation of latent infection of the adipose tissue. Investigating
these aspects will require the development an appropriate animal
model of intra-adipose tissue mycobacterial persistence in order to
study resistance to antibiotics, efficacy of various types of immune
responses, and reactivation factors. Mycobacterial persistence
within cells or tissue with limited antigen presentation abilities
([38] and data not shown) may be of great advantage for the
tubercle bacillus. This may prove challenging for the design of
future vaccines to combat persistent mycobacteria and prevent
reactivating TB. Finally, our results may show relevance for other
mycobacterial diseases, likely affecting the adipose tissue, such as
Hansen’s disease and Buruli ulcer.
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